Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up

To report the long-term safety and efficacy data of a third generation drug eluting stent (DES) with biodegradable polymer in the complex patient population of diabetes mellitus after a follow-up period of 5 years